Approval in 2 Weeks via FDA ' s New Oncology Drugs Review Approval in 2 Weeks via FDA ' s New Oncology Drugs Review

Approval of a new indication took only 2 weeks with the FDA ' s new program for reviewing oncology drugs. It involved expanded use of the lymphoma drug brentuximab vedotin.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news